Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Hari

Showing results (71-80 of 255) with videos related to

Pageof 26
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic AdvancesLaurent Garderet, Anita D'Souza, Paulette Jacobs, et al.
International Journal of Cardiology|May 19, 2009
Systemic and microvascular oxidative stress induced by light chain amyloidosisRaymond Q Migrino, Parameswaran Hari, David D Gutterman, et al.
Hematology/Oncology and Stem Cell Therapy|March 19, 2019
Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced diseaseGina Patel, Parameswaran Hari, Aniko Szabo, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2020
Monoclonal Gammopathies After Renal Transplantation: A Single-center StudyBhavna Bhasin, Aniko Szabo, Ruizhe Wu, et al.
Case Reports in Hematology|November 16, 2016
Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with RuxolitinibMaheen Z Abidi, Javeria Haque, Parvathi Varma, et al.
Blood Reviews|August 19, 2020
Autonomic nervous system control of multiple myelomaYan Cheng, Fumou Sun, Anita D'Souza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2011
Tocilizumab for the treatment of steroid refractory graft-versus-host diseaseWilliam R Drobyski, Marcelo Pasquini, Kathy Kovatovic, et al.
JAMA Oncology|March 10, 2022
Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity SyndromeJoanna C Zurko, Bryon D Johnson, Emilie Aschenbrenner, et al.
Acta Haematologica|March 30, 2018
Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction ChemotherapyRobert Schneidewend, Paul Hosking, Ruta Brazauskas, et al.
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
Pageof 26

Showing results (71-80 of 255) with videos related to

Sort By:
Pageof 26
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 13, 2017
Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic AdvancesLaurent Garderet, Anita D'Souza, Paulette Jacobs, et al.
International Journal of Cardiology|May 19, 2009
Systemic and microvascular oxidative stress induced by light chain amyloidosisRaymond Q Migrino, Parameswaran Hari, David D Gutterman, et al.
Hematology/Oncology and Stem Cell Therapy|March 19, 2019
Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced diseaseGina Patel, Parameswaran Hari, Aniko Szabo, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2020
Monoclonal Gammopathies After Renal Transplantation: A Single-center StudyBhavna Bhasin, Aniko Szabo, Ruizhe Wu, et al.
Case Reports in Hematology|November 16, 2016
Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with RuxolitinibMaheen Z Abidi, Javeria Haque, Parvathi Varma, et al.
Blood Reviews|August 19, 2020
Autonomic nervous system control of multiple myelomaYan Cheng, Fumou Sun, Anita D'Souza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2011
Tocilizumab for the treatment of steroid refractory graft-versus-host diseaseWilliam R Drobyski, Marcelo Pasquini, Kathy Kovatovic, et al.
JAMA Oncology|March 10, 2022
Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity SyndromeJoanna C Zurko, Bryon D Johnson, Emilie Aschenbrenner, et al.
Acta Haematologica|March 30, 2018
Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction ChemotherapyRobert Schneidewend, Paul Hosking, Ruta Brazauskas, et al.
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
Pageof 26